![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](ci2885contents.gif)
Acta Cryst. (2009). E65, o2603 [ doi:10.1107/S1600536809039002 ]
Abstract: In the title compound, C16H16N2O3S·C5H5N, the benzene and thiazole rings of the Febuxostat [2-(3-cyano-4-isobutyloxy)phenyl-4-methyl-5-thiazolecarboxylic acid] molecule are almost coplanar [dihedral angle = 2.4 (1)°]. The carboxyl group is coplanar with the thiazole ring [O-C-C-C and O-C-C-S torsion angles of -0.7 (4) and 0.6 (3)°, respectively]. The pyridine molecule of crystallization is linked to the Febuxostat molecule through an O-H
N hydrogen bond. A weak
-
stacking interaction is observed between the benzene ring of the Febuxostat molecule and pyridine molecule, with a centroid-centroid distance of 3.7530 (18) Å.
Online 3 October 2009
Copyright © International Union of Crystallography
IUCr Webmaster